Gene therapy research program (gtrp) - pharmacology/toxicology core laboratory: task area d - RSA no. 2041
Ended Awarded Last action
- Contract number
- 75N92020F00001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $352,485
Award facts
- Opportunity
-
- Gene Therapy Resource Program (GTRP) Pre-Solicitation · Posted Sep 19, 2017
- Contract value 100% obligated
- $352,485.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$36,103 | |
| Definitize Change Order | $0 | |
| Funding Only Action | $71,386 | |
| Definitize Change Order | $0 | |
| Original award | $317,202 |
About this award
This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a prime contractor and subcontractor for preclinical research services, including animal studies, analytical testing, and disease model development, for HHS agencies like the Biomedical Advanced Research and Development Authority (BARDA). They also hold various indefinite delivery contracts and blanket purchase agreements with HHS and the Department of Defense to provide flexible contracting mechanisms for these types of preclinical research services.
Quick answers
Who was awarded contract 75N92020F00001?
75N92020F00001 was awarded to Lovelace Biomedical Research Institute by National Heart Lung and Blood Institute (National Institutes of Health) on June 8, 2020.
How much is contract 75N92020F00001 worth?
The government has obligated $352,485 on 75N92020F00001.
Is contract 75N92020F00001 an order under another contract?
Yes. 75N92020F00001 is a delivery order under 75N92019D00017, an indefinite delivery contract.
Was contract 75N92020F00001 competed?
The extent of competition for 75N92020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award